STOCK TITAN

Vanguard Discloses 9.42M Shares of Acadia Healthcare (10.19%)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group reported owning 9,417,045 shares of Acadia Healthcare Company, Inc., representing 10.19% of the outstanding common stock as of 09/30/2025. Vanguard reports 0 shares of sole voting power, 598,737 shares of shared voting power, 8,718,595 shares of sole dispositive power, and 698,450 shares of shared dispositive power. The filing states these shares are held in the ordinary course of business and not for the purpose of changing or influencing control. The reporting address is 100 Vanguard Blvd., Malvern, PA, and the filing is signed by Ashley Grim, Head of Global Fund Administration, on 10/06/2025.

Positive

  • Material passive stake: Vanguard holds 9,417,045 shares, equal to 10.19% of the class
  • Clear non‑control intent: Filed on Schedule 13G indicating holdings are ordinary course of business and not to influence control

Negative

  • None.

Insights

Vanguard holds a material passive stake of just over 10% in Acadia Healthcare.

Holding 9.42M shares and 10.19% of the class places Vanguard among significant institutional holders; the position is reported under Schedule 13G, which signals a passive, non-control intent.

Key dependencies include whether other large holders file active disclosures; monitor any future amendments or Schedule 13D filings for changes in intent within the next 30–90 days.

The voting profile shows limited sole voting power and meaningful dispositive authority.

Vanguard reports 0 sole voting power but 598,737 shared voting votes and substantial sole dispositive power, indicating control over trades but limited unilateral voting control. This split is common for asset managers holding client-directed accounts.

Watch for proxy-season activity or coordination with other large holders ahead of any significant governance votes in the coming year.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How many Acadia Healthcare (ACHC) shares does Vanguard report owning?

Vanguard reports owning 9,417,045 shares of ACHC, representing 10.19% of the class.

Does Vanguard claim voting control over the ACHC shares?

Vanguard reports 0 shares of sole voting power and 598,737 shares of shared voting power, indicating no sole voting control.

What type of SEC schedule was filed for Vanguard's ACHC position?

The filing is a Schedule 13G (Amendment No. 9), which is used for passive investors reporting beneficial ownership.

When is the reporting date for the Vanguard Schedule 13G for ACHC?

The event date requiring the filing is 09/30/2025, and the signature is dated 10/06/2025.

Who signed the Schedule 13G for Vanguard on ACHC?

The filing is signed by Ashley Grim, Head of Global Fund Administration.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:10/06/2025